Hospital Acquired Infection Control Market Size, Share & Trends Analysis Report By Type (Equipment, Services, Consumables), By End Use (Hospitals & ICUs, Ambulatory Surgical and Diagnostic Centers), By Region, And Segment Forecasts, 2024 - 2030

Hospital Acquired Infection Control Market Size, Share & Trends Analysis Report By Type (Equipment, Services, Consumables), By End Use (Hospitals & ICUs, Ambulatory Surgical and Diagnostic Centers), By Region, And Segment Forecasts, 2024 - 2030


Hospital Acquired Infection Control Market Growth & Trends

The global hospital acquired infection control market size is anticipated to reach USD 30.86 billion by 2030, growing at a CAGR of 6.65% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of different types of hospital acquired infections, growing awareness of the environment & personal hygiene due to COVID-19, and technological advancements contribute to the demand for hospital acquired infection control devices.

Technologies such as UV-C disinfection robots, advanced air filtration systems, and antimicrobial surfaces are becoming increasingly prevalent, aiming to reduce the spread of pathogens within hospital environments. Moreover, there is a significant emphasis on training healthcare professionals in infection control practices, promoting hand hygiene, and implementing strict protocols for the sterilization of medical instruments & devices. Moreover, regulatory bodies across the globe are implementing rigorous guidelines & recommendations to ensure compliance and effectiveness in infection control measures. Thus, this trend is driving market growth and improving patient outcomes & safety in healthcare facilities.

Furthermore, the integration of IT solutions and electronic surveillance systems into infection control protocols has revolutionized how healthcare facilities monitor and manage infection risks. For instance, in May 2024, HSE Acute and Community Services, AMRIC, and eHealth are launching a National Clinical Surveillance IT System for Infection and Prevention Control (IPC) designed to enhance the management of Healthcare Associated Infections (HCAIs). This integrated system centralizes IPC information, improves access & efficiency, supports timely outbreak management, and reduces administrative burdens, ultimately benefiting patients, service users, & staff. Real-time data analytics helps identify outbreak patterns, track infection rates, and evaluate the effectiveness of implemented control measures.

Moreover, the COVID-19 pandemic highlighted the importance of continuous hygiene monitoring, prompting a shift toward innovative technologies for better infection control. For instance, in August 2020, Sotera Health acquired Iotron Industries, a Canadian company. This acquisition expanded Sotera's Electron Beam (EBeam) capabilities and enhanced its business with Sterigenics with additional expertise. This proactive approach, stimulated by insights from the COVID-19 crisis, is expected to further drive the expansion of the hospital-acquired infection control market.

Hospital Acquired Infection Control Market Report Highlights
  • Based on type, the consumables segment dominated the market in 2023, owing to the increasing awareness of HAIs and stricter regulatory requirements, which have led to the consistent demand for these consumables, which are essential in preventing the spread of infections.
  • Based on end use, the hospitals and Intensive Care Units (ICUs) segment dominated the market in 2023 as regulatory bodies and accreditation organizations are increasingly prioritizing infection prevention within hospital and ICU settings, driving the adoption of comprehensive infection control protocols in these facilities.
  • North America region held the largest market share in 2023, which is attributed to the increasing prevalence of HAIs, presence of major market players and widespread adoption of infection control protocols due to stringent regulatory framework.
  • In March 2024, W&H launched a new eLog system that automatically records and saves sterilization cycles & routine tests in a digital logbook, ensuring compliance with documentation requirements and improving workflow efficiency. In addition, the company introduced the Helix test for optimal process control in type B sterilizers.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of different types of hospital acquired infections
3.2.1.2. Growing awareness of environment & personal hygiene due to COVID-19
3.2.1.3. Technology advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of awareness regarding hospital acquired infection
3.2.2.2. Negative effects of using chemical disinfectant
3.2.3. Market Opportunity Analysis
3.2.4. Market Threat Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis – Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Type Business Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Equipment
4.4.1. Equipment market, 2018 - 2030 (USD Million)
4.4.2. Sterilization Equipment
4.4.2.1. Sterilization Equipment Market, 2018 - 2030 (USD Million)
4.4.2.2. Heat Sterilization Equipment
4.4.2.2.1.Heat Sterilization Equipment Market, 2018 - 2030 (USD Million)
4.4.2.3. Low Temperature Sterilization
4.4.2.3.1.Low Temperature Sterilization Market, 2018 - 2030 (USD Million)
4.4.2.4. Radiation Sterilization
4.4.2.4.1.Radiation Sterilization Market, 2018 - 2030 (USD Million)
4.4.3. Disinfection Equipment
4.4.3.1. Disinfection Equipment Market, 2018 - 2030 (USD Million)
4.4.3.2. Washer Disinfector
4.4.3.2.1.Washer Disinfector Market, 2018 - 2030 (USD Million)
4.4.3.3. Flusher Disinfector
4.4.3.3.1.Flusher Disinfector Market, 2018 - 2030 (USD Million)
4.4.3.4. Endoscopic Reprocessor Systems
4.4.3.4.1.Endoscopic Reprocessor Systems Market, 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Services Market, 2018 - 2030 (USD Million)
4.6. Consumables
4.6.1. Consumables Market, 2018 - 2030 (USD Million)
4.6.1.1. Disinfectants
4.6.1.1.1.Disinfectants Market, 2018 - 2030 (USD Million)
4.6.1.2. Sterilization Consumables
4.6.1.2.1.Sterilization Consumables Market, 2018 - 2030 (USD Million)
Chapter 5. End Use Business Analysis
5.1. End Use Market Share, 2023 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals and Intensive Care Units (ICUs)
5.4.1. Hospitals and Intensive Care Units (ICUs) Market, 2018 - 2030 (USD Million)
5.5. Ambulatory Surgical and Diagnostic Centres
5.5.1. Ambulatory Surgical and Diagnostic Centres Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Estimates & Trend Analysis by Component
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamic
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamic
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamic
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamic
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamic
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamic
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamic
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamic
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key country dynamic
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Norway hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamic
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Denmark hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key country dynamic
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Sweden hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key country dynamic
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Japan hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key country dynamic
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. China hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamic
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key country dynamic
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. South Korea hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key country dynamic
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. Australia hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key country dynamic
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. Thailand hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamic
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamic
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key country dynamic
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. South Africa hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamic
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Saudi Arabia hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key country dynamic
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. UAE hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key country dynamic
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Kuwait hospital acquired infection control market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. 3M
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Belimed Inc.
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. O&M Halyards
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Getinge
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. ASP (Advanced Sterilization Products Services, Inc.)
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Sterigenics U.S., LLC - A Sotera Health Company
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. MMM Group
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Midmark Corporation
7.5.8.1. Overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. STERIS*
7.5.9.1. Overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
7.5.10. W&H
7.5.10.1. Overview
7.5.10.2. Financial performance
7.5.10.3. Product benchmarking
7.5.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings